<p><h1>Circulating Biomarker Market Growth, Market Trends, COVID-19 Impact, and Forecasts for period from 2024 - 2031</h1></p><p><strong>Circulating Biomarker Market Analysis and Latest Trends</strong></p>
<p><p>Circulating biomarkers are biological molecules or substances that are found in body fluids such as blood, urine, or cerebrospinal fluid. These biomarkers can provide valuable information about a person's health or the presence of a disease. They are extensively used in medical diagnostics, disease prognosis, and monitoring therapeutic responses.</p><p>The circulating biomarker market has been experiencing significant growth in recent years. This growth can be attributed to various factors such as the increasing prevalence of chronic diseases, advancements in technology, rising demand for minimally invasive diagnostic procedures, and the growing focus on personalized medicine.</p><p>Additionally, the ability of circulating biomarkers to offer non-invasive and real-time disease detection and monitoring has further fueled the market growth. The development of new biomarker assays and the advent of high-throughput technologies have expanded the scope of research and applications in this field.</p><p>The market is also witnessing a rising demand for liquid biopsy, a non-invasive diagnostic technique that utilizes circulating biomarkers for cancer detection and monitoring. Liquid biopsy offers advantages over conventional biopsy methods such as ease of sample collection, lower costs, and the ability to monitor disease progression and treatment response over time.</p><p>Furthermore, collaborations and partnerships between academic institutions, research organizations, and biotechnology companies are driving innovation and the development of novel biomarkers. These collaborations enable the validation and commercialization of biomarkers for use in clinical settings.</p><p>Overall, the circulating biomarker market is expected to continue its growth trajectory during the forecast period, with a projected CAGR of 9.9%. The increasing application of circulating biomarkers in disease diagnosis, monitoring, and personalized medicine, coupled with ongoing technological advancements, is anticipated to drive market expansion.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1900390">https://www.reliableresearchreports.com/enquiry/request-sample/1900390</a></p>
<p>&nbsp;</p>
<p><strong>Circulating Biomarker Major Market Players</strong></p>
<p><p>The circulating biomarker market is highly competitive, with several key players dominating the industry. Some of the major players in this market include Abbott Laboratories, Becton, Dickinson and Company (BD), GE Healthcare, Epigenomics AG, Agilent Technologies, Biocept, Affymetrix, and Fluxion Biosciences.</p><p>Abbott Laboratories is a global healthcare company that manufactures and sells a wide range of products, including diagnostic devices. In the circulating biomarker market, Abbott Laboratories offers solutions such as the ARCHITECT i2000SR and the Alinity ci-series systems. Abbott Laboratories has witnessed significant market growth due to its extensive product portfolio and strong presence in the healthcare industry.</p><p>BD, a leading medical technology company, is a key player in the circulating biomarker market. BD offers various products and services, including diagnostic and research tools. The company's NanoString nCounter Analysis System is widely used for the detection and analysis of circulating biomarkers. BD also has a strong market presence and has experienced substantial growth in recent years.</p><p>GE Healthcare, a subsidiary of General Electric, is a prominent player in the circulating biomarker market. The company offers advanced diagnostic imaging systems and medical device solutions. GE Healthcare's biomarker analysis tools, such as the IN Cell Analyzer and IN Carta, are widely used in research laboratories and healthcare facilities. The company has a strong market position and continues to focus on research and development to expand its product portfolio.</p><p>Epigenomics AG is a molecular diagnostic company that specializes in the development of blood-based tests for early cancer detection. The company's flagship product, Epi proColon, is a blood-based screening test for colorectal cancer. Epigenomics AG has witnessed significant market growth due to increasing adoption of its products and partnerships with major healthcare organizations.</p><p>While specific sales revenue figures for the listed companies are not available, it is worth noting that the global circulating biomarker market size was valued at around $12.3 billion in 2020 and is expected to reach $29.0 billion by 2028, growing at a CAGR of 11.7% during the forecast period. The market growth is attributed to the increasing prevalence of chronic diseases, rising demand for non-invasive diagnostic techniques, and advancements in technology.</p><p>Overall, the circulating biomarker market is highly competitive, with several key players driving innovation in this field. The market size is projected to grow significantly in the coming years, offering numerous opportunities for companies to expand their product portfolios and capture a larger market share.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Circulating Biomarker Manufacturers?</strong></p>
<p><p>The circulating biomarker market is experiencing significant growth and is expected to continue this trend in the future. Circulating biomarkers such as nucleic acids, proteins, and extracellular vesicles are used for disease diagnosis, prognosis, and monitoring. The increasing prevalence of chronic diseases, growing demand for personalized medicine, and advancements in technology are the key factors driving market growth. Additionally, the availability of funding for biomarker research and development and increasing focus on precision medicine are further propelling the market's expansion. With ongoing research and development activities, the circulating biomarker market is anticipated to witness a positive outlook in the coming years.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1900390">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1900390</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Circulating Biomarker Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Circulating DNA</li><li>Circulating Tumor Cells</li><li>Other</li></ul></p>
<p><p>The circulating biomarker market consists of various types, such as circulating DNA, circulating tumor cells, and other biomarkers. Circulating DNA refers to fragments of genetic material that are released by cells into the bloodstream. They can provide important information about various conditions, including cancer, and are commonly used for diagnostic and monitoring purposes. Similarly, circulating tumor cells are cancer cells that have detached from a tumor and entered the bloodstream. These cells are considered valuable indicators of cancer progression and treatment response. Lastly, other circulating biomarkers may include proteins, RNA molecules, or exosomes, which can provide further insights into disease states and therapeutic targets.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/1900390">https://www.reliableresearchreports.com/purchase/1900390</a></p>
<p>&nbsp;</p>
<p><strong>The Circulating Biomarker Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospital</li><li>Medical Research Center</li><li>Others</li></ul></p>
<p><p>The circulating biomarker market finds application in several sectors such as hospitals, medical research centers, and others. In hospitals, circulating biomarkers are utilized for early detection and diagnosis of diseases, enabling effective patient management. Medical research centers employ circulating biomarkers to conduct studies on disease progression and therapeutic efficacy. The "others" market includes applications like forensic testing and drug development. Overall, circulating biomarkers play a crucial role in improving healthcare outcomes and advancing medical research across various sectors.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Circulating Biomarker Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The circulating biomarker market is expected to experience significant growth in various regions, including North America (NA), Asia Pacific (APAC), Europe, the United States of America (USA), and China. Various factors such as increasing prevalence of chronic diseases, advancements in technology, and rising focus on personalized medicine are driving the market growth. Among these regions, North America is projected to dominate the market, occupying the largest market share at approximately 35%, followed by Europe at 28%. Asia Pacific is anticipated to witness the highest growth rate, owing to the increasing healthcare expenditure and growth in the biotechnology industry.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/1900390">https://www.reliableresearchreports.com/purchase/1900390</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/1900390">https://www.reliableresearchreports.com/enquiry/request-sample/1900390</a></p>
<p><strong></strong></p>
<p><p><a href="https://github.com/cynthiasecret7/Market-Research-Report-List-1/blob/main/pediatric-medicines-market.md">Pediatric Medicines Market</a></p><p><a href="https://medium.com/@isomgleason/hygienic-nonwoven-fabric-market-size-cagr-trends-2024-2030-db7578423b65">Hygienic Nonwoven Fabric Market</a></p><p><a href="https://medium.com/@isomgleason/whitening-mask-market-analysis-its-cagr-market-segmentation-and-global-industry-overview-94c49740599c">Whitening Mask Market</a></p><p><a href="https://github.com/violetap1969/Market-Research-Report-List-1/blob/main/tyrosine-kinase-inhibitors-market.md">Tyrosine Kinase Inhibitors Market</a></p><p><a href="https://medium.com/@isomgleason/drinking-bottled-natural-mineral-water-market-report-reveals-the-latest-trends-and-growth-0fd76fc034e4">Drinking Bottled Natural Mineral Water Market</a></p></p>